Theriva Biologics (TOVX) Liabilities from Discontinued Operations (2010)
Theriva Biologics (TOVX) posted quarterly Liabilities from Discontinued Operations of 24000.0 for Q4 2010.
Theriva Biologics (TOVX) Liabilities from Discontinued Operations (2010) Analysis & Trends
Theriva Biologics (TOVX) has reported Liabilities from Discontinued Operations for 1 consecutive years, with 24000.0 the latest figure, recorded in Q4 2010.
- In Q4 2010, Liabilities from Discontinued Operations changed N/A year-over-year to 24000.0; the TTM figure through Dec 2010 stood at 24000.0 (changed N/A YoY), while the FY2010 annual figure was 24000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations held at 24000.0 in Q4 2010 per TOVX's latest filing.
- Across five years, Liabilities from Discontinued Operations topped out at 24000.0 in Q4 2010 and bottomed at 24000.0 in Q4 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Theriva Biologics | 10.64 Mn | 10.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 24,000.00 |
| Dec 31, 2010 | 24,000.00 |